Zobrazeno 1 - 10
of 65
pro vyhledávání: '"RC Jankowitz"'
Publikováno v:
Cancer Research. 79:P3-15
Background: Breast cancer is a leading cause of death in women. Metastatic breast cancer (MBC) was the leading cause of death among the 41,000 patients with breast cancer who died this year. The number of available clinical trials for breast cancer p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d64f74b6959b78faf59bd6b2a7e9c869
https://doi.org/10.1158/1538-7445.sabcs18-p3-15-01
https://doi.org/10.1158/1538-7445.sabcs18-p3-15-01
Autor:
Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Tayob N; Harvard Medical School, Boston, MA.; Division of Data Science, Dana-Farber Cancer Institute, Boston, MA., Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Oncology Data Science Vall d'Hebron Institute of Oncology, Barcelona, Spain., Dang C; Memorial Sloan Kettering Cancer Center, New York, NY., Yardley DA; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN., Isakoff SJ; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA., Valero V; MD Anderson Cancer Center, Houston, TX., Faggen M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Mulvey T; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA., Bose R; Washington University School of Medicine, St Louis, MO., Weckstein D; New Hampshire Oncology Hematology, Manchester, NH., Wolff AC; Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC., Reeder-Hayes K; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Rugo HS; University of California, San Francisco, CA., Ramaswamy B; Ohio State University Comprehensive Cancer Center, Columbus, OH., Zuckerman D; St Luke's Mountain States Tumor Institute, Boise, ID., Hart L; Wake Forest Baptist Health, Winston-Salem, NC., Gadi VK; University of Illinois Cancer Center, Chicago, IL., Constantine M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cheng K; North Shore-LIJ Cancer Institute, Lake Success, NY., Garrett AM; Northern Light Cancer Care, Brewer, ME., Marcom PK; Duke University School of Medicine, Durham, NC., Albain K; Loyola University Medical Center, Maywood, IL., DeFusco P; Hartford Healthcare Cancer Institute, Hartford, CT., Tung N; Harvard Medical School, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA., Ardman B; Lowell General Hospital, Lowell, MA., Nanda R; UChicago Medicine, Chicago, IL., Jankowitz RC; Perelman Center for Advanced Medicine, Philadelphia, PA., Rimawi M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Abramson V; Vanderbilt-Ingram Cancer Center, Nashville, TN., Pohlmann PR; MD Anderson Cancer Center, Houston, TX.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC., Van Poznak C; Rogel Cancer Center, University of Michigan, Ann Arbor, MI., Forero-Torres A; Kirklin UAB Hematology Oncology, Birmingham, AL., Liu MC; Natera, Inc, Austin, TX., Ruddy KJ; Mayo Clinic, Rochester, NY., Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., DeMeo M; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Dell'Orto P; IEO European Institute of Oncology, IRCCS, Milan, Italy., Russo L; IEO European Institute of Oncology, IRCCS, Milan, Italy., Krause E; PathAI, Boston, MA., Newhouse DJ; NanoString Technologies, Inc, Boston, MA., Kurt BB; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA., Schneider B; Indiana University School of Medicine, Indianapolis, IN., Prat A; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT., Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov; Vol. 42 (31), pp. 3652-3665. Date of Electronic Publication: 2024 Jun 27.
Autor:
Oesterreich S; University of Pittsburgh, Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Women's Cancer Research Center, Magee Womens Research Institute, Pittsburgh, PA, USA. oesterreichs@upmc.edu., Pate L; Independent ILC Advocate, Founder LBCA, Pittsburgh, PA, USA., Lee AV; University of Pittsburgh, Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Women's Cancer Research Center, Magee Womens Research Institute, Pittsburgh, PA, USA.; Institute for Precision Medicine, University of Pittsburgh and UPMC, Pittsburgh, PA, USA., Chen F; University of Pittsburgh, Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Women's Cancer Research Center, Magee Womens Research Institute, Pittsburgh, PA, USA.; Tsinghua University, Beijing, China., Jankowitz RC; University of Pennsylvania and Penn Medicine Abramson Cancer Center, Philadelphia, PA, USA., Mukhtar R; University of California, San Francisco, Department of Surgery, San Francisco, CA, USA., Metzger O; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, MA, USA., Sikora MJ; Dept. of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Li CI; Fred Hutchinson Cancer Center, Division of Public Health Sciences, Seattle, WA, USA., Sotiriou C; Jules Bordet Institute Belgium, Brussels, Belgium., Shah OS; University of Pittsburgh, Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Women's Cancer Research Center, Magee Womens Research Institute, Pittsburgh, PA, USA., Koorman T; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Ulaner G; Molecular Imaging and Therapy, Hoag Family Cancer Institute, Molecular Imaging and Therapy, Irvine, CA. Departments of Radiology and Translational Genomics, University of Southern California, Los Angeles, CA, USA., Reis-Filho JS; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; AstraZeneca, GAITHERSBURG, MARYLAND, USA., Davidson NM; Fred Hutchinson Cancer Center, Division of Public Health Sciences, Seattle, WA, USA., Van Baelen K; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Hutcheson L; Lobular Breast Cancer Alliance Inc., White Horse Beach, MA, USA., Freeney S; Lobular Ireland, Dublin, Ireland., Migyanka F; Dynami Foundation, Wausau, WI, USA., Turner C; Lobular Breast Cancer UK, Nottingham, UK., Derksen P; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Bear T; Department of Family Medicine, University of Pittsburgh, Pittsburgh, patients/advocates, Pittsburgh, PA, USA., Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Jul 20; Vol. 10 (1), pp. 61. Date of Electronic Publication: 2024 Jul 20.
Autor:
Gradishar WJ; Robert H . Lurie Comprehensive Cancer Center of Northwestern University., Moran MS; Yale Cancer Center/Smilow Cancer Hospital., Abraham J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Abramson V; Vanderbilt-Ingram Cancer Center., Aft R; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine., Agnese D; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Allison KH; Stanford Cancer Institute., Anderson B; University of Wisconsin Carbone Cancer Center., Bailey J; University of Michigan Rogel Cancer Center., Burstein HJ; Dana-Farber/Brigham and Women's Cancer Center., Chen N; The UChicago Medicine Comprehensive Cancer Center., Chew H; UC Davis Comprehensive Cancer Center., Dang C; Memorial Sloan Kettering Cancer Center., Elias AD; University of Colorado Cancer Center., Giordano SH; The University of Texas MD Anderson Cancer Center., Goetz MP; Mayo Clinic Comprehensive Cancer Center., Jankowitz RC; Abramson Cancer Center at the University of Pennsylvania., Javid SH; Fred Hutchinson Cancer Center., Krishnamurthy J; Fred & Pamela Buffett Cancer Center., Leitch AM; UT Southwestern Simmons Comprehensive Cancer Center., Lyons J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., McCloskey S; UCLA Jonsson Comprehensive Cancer Center., McShane M; Fox Chase Cancer Center., Mortimer J; City of Hope National Medical Center., Patel SA; Fox Chase Cancer Center., Rosenberger LH; Duke Cancer Institute., Rugo HS; UCSF Helen Diller Family Comprehensive Cancer Center., Santa-Maria C; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Schneider BP; Indiana University Melvin and Bren Simon Comprehensive Cancer Center., Smith ML; Research Advocacy Network., Soliman H; Moffitt Cancer Center., Stringer-Reasor EM; O'Neal Comprehensive Cancer Center at UAB., Telli ML; Stanford Cancer Institute., Wei M; Huntsman Cancer Institute at the University of Utah., Wisinski KB; University of Wisconsin Carbone Cancer Center., Yeung KT; UC San Diego Moores Cancer Center., Young JS; Roswell Park Comprehensive Cancer Center., Schonfeld R; National Comprehensive Cancer Network., Kumar R; National Comprehensive Cancer Network.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Jul; Vol. 22 (5), pp. 331-357.
Autor:
Jacobs SA; NSABP Foundation, Pittsburgh, PA, USA. jacobssa1945@gmail.com., Wang Y; NSABP Foundation, Pittsburgh, PA, USA., Abraham J; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Taussig Cancer Institute, Weston, Cleveland, OH, USA., Feng H; NSABP Foundation, Pittsburgh, PA, USA., Montero AJ; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Taussig Cancer Institute, Weston, Cleveland, OH, USA.; University Hospitals/Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Lipchik C; NSABP Foundation, Pittsburgh, PA, USA., Finnigan M; NSABP Foundation, Pittsburgh, PA, USA., Jankowitz RC; NSABP Foundation, Pittsburgh, PA, USA.; University of Pittsburgh, Pittsburgh, PA, USA.; University of Pennsylvania Perelman School of Medicine, State College, Philadelphia, PA, USA., Salkeni MA; NSABP Foundation, Pittsburgh, PA, USA.; National Institutes of Health, Washington, DC, USA.; Virginia Cancer Specialists, Fairfax, VA, USA., Maley SK; NSABP Foundation, Pittsburgh, PA, USA., Puhalla SL; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Piette F; International Drug Development Institute, Louvain-la-Neuve, Belgium., Quinn K; Guardant Health, Redwood City, CA, USA., Chang K; Guardant Health, Redwood City, CA, USA., Nagy RJ; Guardant Health, Redwood City, CA, USA., Allegra CJ; NSABP Foundation, Pittsburgh, PA, USA.; University of Florida Health, Gainesville, FL, USA., Vehec K; NSABP Foundation, Pittsburgh, PA, USA., Wolmark N; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Lucas PC; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Srinivasan A; NSABP Foundation, Pittsburgh, PA, USA.; Autism Impact Fund, Pittsburgh, PA, USA., Pogue-Geile KL; NSABP Foundation, Pittsburgh, PA, USA.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 May 24; Vol. 26 (1), pp. 83. Date of Electronic Publication: 2024 May 24.
Autor:
Jacobs SA; NSABP Foundation, Pittsburgh, PA, USA. jacobssa1945@gmail.com., Wang Y; NSABP Foundation, Pittsburgh, PA, USA., Abraham J; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Weston/Taussig Cancer Institute, Cleveland, OH, USA., Feng H; NSABP Foundation, Pittsburgh, PA, USA., Montero AJ; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Weston/Taussig Cancer Institute, Cleveland, OH, USA.; University Hospitals/Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Lipchik C; NSABP Foundation, Pittsburgh, PA, USA., Finnigan M; NSABP Foundation, Pittsburgh, PA, USA., Jankowitz RC; NSABP Foundation, Pittsburgh, PA, USA.; University of Pittsburgh, Pittsburgh, PA, USA.; University of Pennsylvania Perelman School of Medicine, State College, PA, USA., Salkeni MA; NSABP Foundation, Pittsburgh, PA, USA.; National Institutes of Health, Washington, DC, USA.; Virginia Cancer Specialists, Fairfax, VA, USA., Maley SK; NSABP Foundation, Pittsburgh, PA, USA., Puhalla SL; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Piette F; International Drug Development Institute, Louvain-la-Neuve, Belgium., Quinn K; Guardant Health, Redwood City, CA, USA., Chang K; Guardant Health, Redwood City, CA, USA., Nagy RJ; Guardant Health, Redwood City, CA, USA., Allegra CJ; NSABP Foundation, Pittsburgh, PA, USA.; University of Florida Health, Gainesville, FL, USA., Vehec K; NSABP Foundation, Pittsburgh, PA, USA., Wolmark N; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Lucas PC; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Srinivasan A; NSABP Foundation, Pittsburgh, PA, USA.; Autism Impact Fund, Pittsburgh, PA, USA., Pogue-Geile KL; NSABP Foundation, Pittsburgh, PA, USA.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Apr 22; Vol. 26 (1), pp. 69. Date of Electronic Publication: 2024 Apr 22.
Autor:
Van Baelen K; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynecological Oncology, University Hospitals Leuven, Leuven, Belgium., Van Cauwenberge J; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynecological Oncology, University Hospitals Leuven, Leuven, Belgium., Maetens M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Beck G; European Lobular Breast Cancer Consortium, Utrecht, the Netherlands., Camden A; Lobular Breast Cancer Alliance inc., Plymouth, MA, USA., Chase MC; Lobular Breast Cancer Alliance inc., Plymouth, MA, USA., Fraser V; Lobular Breast Cancer Alliance inc., Plymouth, MA, USA., Freeney S; European Lobular Breast Cancer Consortium, Utrecht, the Netherlands.; Lobular Ireland, Dublin, Ireland., Hutcheson L; Lobular Breast Cancer Alliance inc., Plymouth, MA, USA., Levine JK; Lobular Breast Cancer Alliance inc., Plymouth, MA, USA., Lien T; European Lobular Breast Cancer Consortium, Utrecht, the Netherlands., Terveer R; European Lobular Breast Cancer Consortium, Utrecht, the Netherlands.; Borstkankervereniging Nederland, Utrecht, the Netherlands., Turner C; European Lobular Breast Cancer Consortium, Utrecht, the Netherlands.; Lobular Breast Cancer UK, Manchester, UK., Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland., Jankowitz RC; Division of Hematology/Oncology, Abramsom Cancer Center, University of Pennsylvania, Philadelphia, USA., Vandecaveye V; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.; Division of Translational MRI, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Floris G; Department of Pathology, University Hospitals Leuven, Leuven, Belgium., Neven P; Department of Gynecological Oncology, University Hospitals Leuven, Leuven, Belgium., Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Sawyer E; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Vincent-Salomon A; Department of Pathology, Institut Curie, Paris Sciences Lettres University, Paris, France., Derksen PWB; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium. christine.desmedt@kuleuven.be.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Mar 20; Vol. 10 (1), pp. 23. Date of Electronic Publication: 2024 Mar 20.
Autor:
Sanft TB; 1Yale School of Medicine, New Haven, CT., Wong J; 2Biotheranostics, A Hologic Company, San Diego, CA., O'Neal B; 2Biotheranostics, A Hologic Company, San Diego, CA., Siuliukina N; 2Biotheranostics, A Hologic Company, San Diego, CA., Jankowitz RC; 3University of Pennsylvania, Philadelphia, PA., Pegram MD; 4Stanford Comprehensive Cancer Institute, Palo Alto, CA., Fox JR; 5Rocky Mountain Cancer Center, US Oncology, Boulder, CO., Zhang Y; 2Biotheranostics, A Hologic Company, San Diego, CA., Treuner K; 2Biotheranostics, A Hologic Company, San Diego, CA., O'Shaughnessy JA; 6Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Mar 04; Vol. 22 (2), pp. 99-107. Date of Electronic Publication: 2024 Mar 04.
Autor:
Lenz L; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Neff C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Solimeno C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Cogan ES; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Abramson VG; Vanderbilt University Medical Center, Nashville, TN, USA., Boughey JC; Mayo Clinic, Rochester, MN, USA., Falkson C; University of Rochester Medical Center, Rochester, NY, USA., Goetz MP; Mayo Clinic, Rochester, MN, USA., Ford JM; Stanford University School of Medicine, Stanford, CA, USA., Gradishar WJ; Northwestern University, Chicago, IL, USA., Jankowitz RC; University of Pennsylvania, Philadelphia, PA, USA., Kaklamani VG; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Marcom PK; Duke University, Durham, NC, USA., Richardson AL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Storniolo AM; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA., Tung NM; Beth Israel Deaconess Medical Center, Boston, MA, USA., Vinayak S; University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, 15. AstraZeneca, Seattle, WA, USA., Hodgson DR; AstraZeneca, Cambridge, UK., Lai Z; AstraZeneca, Boston, MA, USA., Dearden S; AstraZeneca, Cambridge, UK., Hennessy BT; Royal College of Surgeons in Ireland, Dublin, Ireland., Mayer EL; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mills GB; Oregon Health & Science University, Portland, OR, USA., Slavin TP; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Gutin A; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Connolly RM; Cancer Research @UCC, University College Cork, Cork, Ireland., Telli ML; Stanford University School of Medicine, Stanford, CA, USA., Stearns V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Lanchbury JS; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Timms KM; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA. ktimms@myriad.com.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Nov; Vol. 202 (1), pp. 191-201. Date of Electronic Publication: 2023 Aug 17.
Autor:
Manik R; Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA.; Harvard Medical School, Boston, MA, USA., Grady CB; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA., Elmore LC; Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA., Fieber JH; Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA.; Division of Surgical Oncology, Department of Surgery, University of Florida, Gainesville, FL, USA., Freedman GM; Rena Rowan Breast Center, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA, USA.; Department of Radiation Oncology, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA., Jankowitz RC; Rena Rowan Breast Center, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA., Tchou JC; Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA.; Rena Rowan Breast Center, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA, USA.; Leonard Davis Institute of Health Economics (LDI), The University of Pennsylvania, Philadelphia, PA, USA., Zhang JQ; Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA.; Rena Rowan Breast Center, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA, USA., Hubbard RA; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA., Fayanju OM; Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA. Oluwadamilola.Fayanju@pennmedicine.upenn.edu.; Rena Rowan Breast Center, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA, USA. Oluwadamilola.Fayanju@pennmedicine.upenn.edu.; Leonard Davis Institute of Health Economics (LDI), The University of Pennsylvania, Philadelphia, PA, USA. Oluwadamilola.Fayanju@pennmedicine.upenn.edu.; Penn Center for Cancer Care Innovation (PC3I), Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA, USA. Oluwadamilola.Fayanju@pennmedicine.upenn.edu.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2023 Oct; Vol. 30 (11), pp. 6506-6515. Date of Electronic Publication: 2023 Jul 17.